Andrew Rackear
2013
In 2013, Andrew Rackear earned a total compensation of $1.2M as Former Vice President and General Counsel at Enzon Pharmaceuticals, a 80% increase compared to previous year.
Compensation breakdown
| Salary | $357,979 |
|---|---|
| Other | $803,050 |
| Total | $1,161,029 |
Rackear received $803.1K in other compensation, accounting for 69% of the total pay in 2013.
Rackear also received $358K in salary.
Rankings
In 2013, Andrew Rackear's compensation ranked 5,970th out of 12,286 executives tracked by ExecPay. In other words, Rackear earned more than 51.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,970 out of 12,286 | 51st |
Division Manufacturing | 2,070 out of 4,612 | 55th |
Major group Chemicals And Allied Products | 605 out of 1,462 | 59th |
Industry group Drugs | 435 out of 1,156 | 62nd |
Industry Biological Products, Except Diagnostic Substances | 66 out of 196 | 66th |
Source: SEC filing on April 16, 2014.
Rackear's colleagues
We found five more compensation records of executives who worked with Andrew Rackear at Enzon Pharmaceuticals in 2013.
2013
Aby Buchbinder
Enzon Pharmaceuticals
Former Vice President, Clinical Development
2013
Charles Conover
Enzon Pharmaceuticals
Former Senior Vice President of Research & Development, Program Management
2013
George Hebard
Enzon Pharmaceuticals
Chief Operating Officer
2013
Timothy Daly
Enzon Pharmaceuticals
Chief Accounting Officer
2013
Richard Feinstein
Enzon Pharmaceuticals